if novartis knows anything about otat outcome, wouldn't we also know.
maybe its because we don't currenty have any evidence that it will benefit in over 65, which is the vast majority of all cause ards cases.
OTAT Meeting, page-32
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 95.0¢ | $358.3K | 374.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 76908 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 13820 | 13 |
View Market Depth
| Last trade - 11.03am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |